145 related articles for article (PubMed ID: 7061920)
1. Triamterene urolithiasis: solubility, pk, effect on crystal formation, and matrix binding of triamterene and its metabolites.
Werness PG; Bergert JH; Smith LH
J Lab Clin Med; 1982 Feb; 99(2):254-62. PubMed ID: 7061920
[TBL] [Abstract][Full Text] [Related]
2. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
Srinivasan S; Kalaiselvi P; Varalakshmi P
Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
[TBL] [Abstract][Full Text] [Related]
3. Triamterene nephrolithiasis.
Ettinger B; Oldroyd NO; Sörgel F
JAMA; 1980 Nov; 244(21):2443-5. PubMed ID: 7431573
[TBL] [Abstract][Full Text] [Related]
4. Triamterene and renal stone formation: the influence of triamterene and triamterene stones on calcium oxalate crystallization.
White DJ; Nancollas GH
Calcif Tissue Int; 1987 Feb; 40(2):79-84. PubMed ID: 3105837
[TBL] [Abstract][Full Text] [Related]
5. Triamterene and renal lithiasis: a review.
Carey RA; Beg MM; McNally CF; Tannenbaum P
Clin Ther; 1984; 6(3):302-9. PubMed ID: 6373008
[TBL] [Abstract][Full Text] [Related]
6. The true composition of kidney stones passed during triamterene therapy.
Sörgel F; Ettinger B; Benet LZ
J Urol; 1985 Nov; 134(5):871-3. PubMed ID: 4057369
[TBL] [Abstract][Full Text] [Related]
7. Modulation of proliferating renal epithelial cell affinity for calcium oxalate monohydrate crystals.
Farell G; Huang E; Kim SY; Horstkorte R; Lieske JC
J Am Soc Nephrol; 2004 Dec; 15(12):3052-62. PubMed ID: 15579508
[TBL] [Abstract][Full Text] [Related]
8. Triamterene and renal stone formation.
White DJ; Nancollas GH
J Urol; 1982 Mar; 127(3):593-7. PubMed ID: 7062445
[TBL] [Abstract][Full Text] [Related]
9. [Drug induced nephrolithiasis: observation of an oxalate and hydroxylated triamterene stone (author's transl)].
Baudin S; Rodrigue H
Nephrologie; 1980; 1(4):183-5. PubMed ID: 7301028
[TBL] [Abstract][Full Text] [Related]
10. [Triamterene and renal calculi].
Daudon M; Protat MF; Réveillaud RJ
Nephrologie; 1982; 3(3):119-23. PubMed ID: 7144994
[TBL] [Abstract][Full Text] [Related]
11. Crystal matrix protein--getting blood out of a stone.
Stapleton AM; Ryall RL
Miner Electrolyte Metab; 1994; 20(6):399-409. PubMed ID: 7783703
[TBL] [Abstract][Full Text] [Related]
12. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
[TBL] [Abstract][Full Text] [Related]
13. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
Khan SR; Thamilselvan S
Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
[TBL] [Abstract][Full Text] [Related]
14. Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones.
Mushtaq S; Siddiqui AA; Naqvi ZA; Rattani A; Talati J; Palmberg C; Shafqat J
Clin Chim Acta; 2007 Sep; 384(1-2):41-7. PubMed ID: 17610860
[TBL] [Abstract][Full Text] [Related]
15. Microstructural matrix-crystal interactions in calcium oxalate monohydrate kidney stones.
Stacholy J; Goldberg EP
Scan Electron Microsc; 1985; (Pt 2):781-7. PubMed ID: 3931207
[TBL] [Abstract][Full Text] [Related]
16. [The effect of takusha and kagosou on calcium oxalate renal stones in rats].
Yamaguchi S; Jihong L; Utsunomiya M; Yoshioka T; Okuyama A; Koide T; Sugiyama K
Hinyokika Kiyo; 1995 Jun; 41(6):427-31. PubMed ID: 7645450
[TBL] [Abstract][Full Text] [Related]
17. Role of crystal surface adhesion in kidney stone disease.
Wesson JA; Ward MD
Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):386-93. PubMed ID: 16775453
[TBL] [Abstract][Full Text] [Related]
18. Crystallization properties in urine from calcium oxalate stone formers.
Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
[TBL] [Abstract][Full Text] [Related]
19. Role of a protein inhibitor isolated from human renal stone matrix in urolithiasis.
Aggarwal S; Tandon C; Forouzandeh M; Singla SK; Kiran R; Jethi RK
Indian J Biochem Biophys; 2005 Apr; 42(2):113-7. PubMed ID: 23923571
[TBL] [Abstract][Full Text] [Related]
20. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
Atmani F; Khan SR
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
